JIR
QDEL icon

James Investment Research’s QuidelOrtho QDEL Stock Holding History

James Investment Research’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,305
Closed -$675K – 762
2019
Q1 		$675K Buy
+10,305
New +$623K 0.04% 356

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

James Investment Research's QDEL Position: Q2 2019 in Review

James Investment Research sold out of QuidelOrtho (QDEL) in Q2 2019, closing a stake of 10,305 shares — an estimated $675K sold.

James Investment Research first reported a position in QDEL in Q1 2019 and held it in 1 quarter. The position peaked at $675K in Q1 2019. 155 funds tracked by Wall St. Rank hold QDEL as of Q2 2019.

  • James Investment Research reported no remaining QuidelOrtho position as of Q2 2019 after selling out during the quarter.
  • James Investment Research sold 10,305 QuidelOrtho shares in Q2 2019, an estimated $675K.
  • James Investment Research first reported a position in QuidelOrtho in Q1 2019 and held it in 1 quarter.
  • James Investment Research's QuidelOrtho position peaked at $675K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2019.

Based on James Investment Research's 13F filing for Q2 2019, filed 24 Jul 2019.